ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

New NCAB Chair Seeks Ideas, Opinions On Cancer Priorities

September 23, 1994

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

NCI Supercomputer Operations To Start In April

November 15, 1985

NCI Reorganization: DEC Epidemiology Stays In Place, DCPC To Build Its Own – No Decision Yet Enters, Other DCPC Program – CIS Moved To OCC, ICIC ut Of OIA

June 24, 1988

Afinitor Increases Overall Survival To 3.5 Years in Phase III Trial

September 26, 2014

Phase III Lung and Pancreatic Cancer Trials Are Stopped

April 30, 2010